
|Videos|December 26, 2016
Access to PCSK9 Inhibitors Remains a Challenge
Author(s)Lauren Santye, Assistant Editor
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.
Advertisement
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, ASH Experts Review Newly Approved Therapies in Hemophilia
2
How a New Generation of CAR T-Cell Therapies Could Reduce the Risk of Rejection
3
Pharmacist Strategies for Managing Comorbid Depression and Diabetes
4
Pharmacy Deserts: A Crisis Health Care Providers Can Help Solve with Technology and Teamwork
5
















































































































































































































